A recent survey reveals a striking trend: 90% of longevity clinics market unproven treatments rather than relying on solid science. Dr Ksenia Butova’s study illustrates how few clinics adopt evidence-based methods, prompting calls for regulatory reform. This highlights a gap between commercial promises and scientific validation.
Q&A
- What defines evidence-based longevity treatment?
- Why do many longevity clinics rely heavily on marketing?
- How can regulation improve the longevity treatment landscape?